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Abstract
Removing dietary phyto-oestrogens in adult male rats causes obesity and diabetes. As whey proteins have been reported to reduce food intake
and improve glucose homoeostasis, we investigated whether they could attenuate susceptibility to obesity and diabetes due to phyto-
oestrogen deprivation. To this end, thirty male Wistar rats were fed a high-phyto-oestrogen (HP) or a phyto-oestrogen-free (PF) diet for
10 weeks; six rats from each group were killed. The remaining HP animals (six animals) continued receiving the HP diet for 6 weeks. The
remaining PF rats (twelve rats) were divided in two groups: one was given the PF diet and the other a variation of the PF diet plus whey
protein (PF-W). Body weight, food intake and adipose tissue weights were recorded. Hypothalamic mRNA expressions of orexigenic
(neuropeptide Y, agouti-related protein (AgRP)) and anorexigenic (pro-opiomelanocortin (POMC), cocaine-amphetamine-related transcript
(CART)) neuropeptides were quantified by real-time PCR. Serum glucose, insulin and total thyroxine (T4), thyroid-stimulating hormone,
testosterone and oestradiol were assessed. After 10 weeks of PF diet, increased body weight, adiposity and energy intake, with up-regulation
of AgRP and down-regulation of POMC', were observed. Longer treatment exacerbated these results, increased total T4 levels, reduced
oestradiol levels and impaired glucose homoeostasis. PF-W reduced energy intake and increased POMC expression; however, body weight
and adiposity remained unchanged. PF-W could not prevent the hormonal changes or the high circulating glucose levels induced by phyto-
oestrogen deprivation, but reduced fasting insulin. These data demonstrate that, although 6 weeks of whey administration could not prevent
obesity in phyto-oestrogen-deprived rats, the reduction in energy intake and circulating insulin could be beneficial with longer treatments.
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Phyto-oestrogens are non-steroidal compounds found in many
legumes and are particularly abundant in soya products. They
have been reported to have a beneficial effect on body weight
and adipose tissue deposition, mainly in postmenopausal
women(1,2). Our group has recently reported that removing
phyto-oestrogens from the diet of male adult rats induces
obesity and diabetes, increasing energy intake through an
orexigenic hypothalamic response mediated by neuropep-
tides(3). The arcuate nucleus in the hypothalamus is the central
area involved in the control of food intake(4,5). This nucleus
contains two distinct populations of neurons: one produces
orexigenic neuropeptides such as agouti-related protein (AgRP)
and neuropeptide Y (NPY), whereas the other synthesises
anorexigenic substances such as cocaine-amphetamine-related
transcript (CART) and pro-opiomelanocortin (POMC)(4,5).
The obesity pandemic can be prevented and managed by
means of different dietary manipulations. At present, energy
restriction is one of the most effective ways for individuals with
obesity to lose weight and ameliorate-related metabolic
diseases. Moreover, altering the macronutrient composition
of the diet may be an effective way to improve food intake
regulation and induce satiety.
Different protein types affect body weight and food intake:
dairy proteins are known to suppress short-term food intake,
increase subjective satiety and stimulate the mechanisms
known to signal satiety(6). However, the contribution of major
Abbreviations: AgRP, agouti-related protein; CART, cocaine-amphetamines-related transcript; E2, oestradiol; HOMA, homoeostasis model assessment.
HP, high phyto-oestrogen; HP-10wk, high-phyto-oestrogen diet administered for 10 weeks; HP-16wk, high-phyto-oestrogen diet administered for 16 weeks;
PF, phyto-oestrogen-free diet; PF-10wk, phyto-oestrogen-free diet administered for 10 weeks; PF-16wk, phyto-oestrogen-free diet administered for 16 weeks;
PF-W, phyto-oestrogen-free diet containing whey; POMC, pro-opiomelanocortin; T4, thyroxine.
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protein fractions such as whey to the control of food intake and
the peripheral and central mechanisms involved have received
little attention.
As whey protein is an abundant by-product in cheese
production (10 litres of milk produces about 9 litres of whey
during cheese manufacturing), it is considered an inexpensive
source of high-quality protein that can be used in functional
foods claiming health benefits(7). Several studies conducted in
humans have shown that whey supplementation affects appetite
and reduces food intake(8–10). However, it is unclear whether the
consumption of whey affects the central mechanisms involved
in food intake control. Animal studies assessing how whey
protein affects food intake have used different experimental
models with diverse amounts of dietary proteins(11–14), as well as
diverse experimental procedures (duration of the treatment,
protein content, use of protein preloads, age and sex of
the subjects, etc.), which make it difficult to draw a definitive
conclusion about the effects of whey on appetite. Thus, further
studies are needed to clarify the role of whey protein in the
central control of energy intake.
Whey proteins have been demonstrated to improve glucose
homoeostasis and insulin sensitivity in both rodent models and
humans(15–17). In addition, whey proteins have been reported to
diminish postprandial glycaemia(18,19) through various inter-
related mechanisms including enhancement of insulin and
release of incretins(15,20). These properties of whey proteins
suggest that they can be used for the management of diabetes
induced by different dietary treatments.
Given the possible beneficial effects of whey for overweight
individuals, the aim of the present study was to evaluate whe-
ther a diet supplemented with whey protein concentrate can
attenuate the susceptibility to obesity and diabetes in adult male
rats previously exposed to a phyto-oestrogen-free (PF) diet,
preventing or reversing alterations in central mechanisms of
energy intake control. We consider that assessing the potential
beneficial effects of whey intake on hyperphagic obese indivi-
duals would be relevant as whey could interfere in the obeso-
genic mechanisms of action of phyto-oestrogen deprivation.
Methods
Preparation of diets
The composition of diets was based on the American Institute of
Nutrition Ad Hoc Committee recommendation for adult rodents
(AIN-93M)(21) and is shown in Table 1. All diets were prepared in-
house using AIN 93 mineral and vitamin mixes, choline chloride,
DL-methionine and α-cellulose from MP Biomedicals and using
local sources of feed-grade sucrose, maize starch, soyabean oil
and casein. A high-phyto-oestrogen (HP) diet was prepared with
the addition of genistein and daidzein (Indofine Chemical Com-
pany). The amounts of phyto-oestrogens added were chosen to
match those present in the regular laboratory chow previously
used by our group(3). The PF was identical to the HP diet but
without the addition of genistein and daidzein. The PF containing
whey protein (PF-W) diet was a variation of the PF diet and
contained whey protein concentrate instead of casein as a source
of dietary protein. Whey protein concentrate (Lacprodan 80) was
kindly provided by Arla Foods Ingredients. The three diets were
isoenergetic, as can be seen in Table 1. The levels of
phyto-oestrogens were quantified in the HP diet, and their
absence in the PF and PF-W diets was confirmed using HPLC
analysis.
Animals and general protocol
All the procedures were approved by the Ethics Committee of
the School of Biochemistry and Biological Sciences (University
of Litoral), and were performed in accordance with the princi-
ples and procedures outlined in the Guide for the Care and Use
of Laboratory Animals issued by the US National Academy of
Sciences(22). In all, thirty adult male Wistar rats were obtained
from the Department of Human Physiology (University of
Litoral). From conception until the beginning of the experiment,
rats were housed under controlled conditions (23± 2°C and
12 h light–12 h dark cycle) with free access to the HP diet. When
the animals reached a weight of 250–300 g, they were randomly
divided into two weight-matched groups and subjected to the
following dietary treatments for 10 weeks. One group (n 12)
was used as control and had ad libitum access to the same HP
diet administered for 10 weeks (HP-10-wk group). To evaluate
the effects of withdrawing phyto-oestrogens from the diet, the
other group (n 18) was fed the PF diet administered for
10 weeks (PF-10-wk group). Body weight was recorded at the
beginning and at the end of the experiment. Food intake was
measured daily during the experimental period, calculating the
weight difference between the offered and remaining food,
adjusted for wastage by calculating food spillage. Energy intake
was calculated by multiplying the amounts of ingested food
with the respective energy contents. At the end of this treat-
ment, six rats from each group were euthanised by decapita-
tion. Trunk blood was collected, samples were centrifuged and
serum was immediately used or frozen and stored at −80°C until
analysis. Epididymal and perirenal fat pads were dissected and
weighed. Immediately after euthanasia, the brain was removed
from the skull, and the medio-basal hypothalamus was dis-
sected (according to Paxinos atlas coordinates −1·0 to −4·5mm
from Bregma and 3mm in depth)(23), snap-frozen in liquid N2
and stored at −80°C until RNA isolation.
Table 1. Composition of the experimental diets
Ingredients HP PF PF-W
Maize starch (g/kg) 621·5 621·5 621·5
Casein (g/kg) 140 140 –
Whey protein concentrate (g/kg) – – 140
Sucrose (g/kg) 100 100 100
Soyabean oil (g/kg) 40 40 40
α-Cellulose (g/kg) 50 50 50
AIN 93 mineral mix (g/kg) 35 35 35
AIN 93 vitamin mix (g/kg) 10 10 10
DL-Met (g/kg) 3·0 3·0 3·0
Choline chloride (g/kg) 1·5 1·5 1·5
Genistein (mg/kg) 190 – –
Daidzein (mg/kg) 210 – –
Energy content (J/g) 15 072 15 072 15072
HP, high-phyto-oestrogen; PF, phyto-oestrogen-free; PF-W, PF diet supplemented
with whey.
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The remaining HP animals (six animals) continued receiving
the HP diet administered for 16 weeks (HP-16wk group),
whereas the remaining PF rats (twelve rats) were divided into
two groups (six rats each): one group was fed the PF diet
administered for 16 weeks (PF-16wk), and the other group
received the PF-W diet to assess whether whey proteins could
prevent or reverse the effects of phyto-oestrogen deprivation.
Body weight and energy intake were also recorded in this
period. At the end of the dietary treatments, the animals were
euthanised and samples were collected as described above.
RNA isolation, reverse transcription and real-time
quantitative PCR
Total RNA was isolated from the hypothalamus using TRIzol
(Invitrogen) according to the manufacturer’s protocol. Reverse
transcription and real-time quantitative PCR were performed as
previously described using specific primer pairs for ribosomal
protein L19 (housekeeping gene), Agrp, Pomc, Cart and Npy(3). In
brief, real-time quantitative PCR was carried out using a SYBR
Green PCR master mix (HOTFIREPol EvaGreen qPCR Mix Plus
(Solis BioDyne, Biocientífica)) and a real-time PCR system
StepOne Cycler (Applied Biosystems Inc., Life Technologies).
Product purity was confirmed by dissociation curves, and random
samples were subjected to agarose gel electrophoresis. All
reactions were carried out at least in triplicate. Fold change from
HP values was determined using the delta–delta Ct method
(24).
Circulating glucose and hormone measurements
Fasting glucose was measured using commercially available kits
(Wiener Lab). Serum insulin was assessed by RIA using an anti-rat
insulin antibody (Sigma) and standard rat insulin provided by
Laboratorios Beta. Thyroid-stimulating hormone was determined by
competitive RIA according to the procedure outlined by Catalano
et al.(25) The levels of total thyroxine (T4), oestradiol (E2) and tes-
tosterone were measured using competitive RIA kits (Immunotech).
Insulin resistance was evaluated according to the homoeostasis
model assessment (HOMA). The HOMA index was calculated
as (fasting insulin (IU/ml)× fasting glucose (mol/l))/22·5(26).
Statistical analysis
Data corresponding to the HP-10-wk and PF-10-wk groups
(expressed as means with their standard errors) were statistically
analysed by Student’s t test. Data from the HP-16wk, PF-16-wk
and PF-W groups (also expressed as means with their standard
errors) were analysed by one-way ANOVA. Post hoc multiple
comparisons were made using Tukey’s critical range test. In all
cases, differences were considered significant at P< 0·05. For all
the analyses, IBM SPSS Statistics 19 software (IBM Inc.) was used.
Results
Effects of 10 weeks of phyto-oestrogen deprivation
Phyto-oestrogen deprivation increased adipose tissue, body
weight and energy intake. Rats fed the PF diet for 10 weeks
significantly increased their body weights (+17%) (Table 2). To
determine whether there was a region-specific fat gain, selected fat
deposits (epididymal and perirenal) were excised and weighed.
Consistent with the changes in body weight, PF-10-wk animals
had significantly greater amounts of epididymal and perirenal fat
than HP-10-wk rats, expressed both in grams (absolute value) and
as a percentage of body weight (Table 2). In close relation to this,
food intake in animals fed the PF diet for 10 weeks was increased.
This hyperphagia led to a significant increase in average energy
intake compared with the HP-10-wk group (Table 2). Energy
intake was higher in PF-10-wk v. HP-10-wk animals throughout
the experiment, as can be seen in Fig. 1.
Increased energy intake was associated with changes in the
hypothalamic expressions of neuropeptides. In rats,
10 weeks of phyto-oestrogen deprivation induced an orexigenic
response by significantly reducing anorexigenic POMC mRNA
expression, increasing orexigenic AgRP and concomitantly
decreasing NPY expression, as compared with the HP-10-wk
group (P< 0·05). CART mRNA levels were unchanged (Fig. 2).
10 Weeks of phyto-oestrogen deprivation did not affect
glucose metabolism. Phyto-oestrogen deprivation did not
affect fasting glucose, insulin or the HOMA index (Table 3).
Effects of whey administration
Whey administration reduced food and energy intake but
did not affect adipose tissue or body weight. When the
animals continued receiving the PF for 6 more weeks, their
body weights remained higher compared with HP-fed rats. This
was reflected in the final body weight (Table 4). PF-W rats
showed a slight reduction in their final body weight that did not
reach statistical significance v. PF-16-wk rats. Fat accretion
observed in rats deprived of phyto-oestrogens for 10 weeks was
exacerbated: compared with HP-16-wk rats, PF-16-wk rats had
significantly greater amounts of epididymal (+50%) and peri-
renal (+60%) fat (Table 4). Consistent with the lack of changes
Table 2. Final body and adipose tissue weights and food and energy
intake in animals fed high-phyto-oestrogen (HP) or phyto-oestrogen-free
(PF) diet for 10 weeks
(Mean values with their standard errors, n 6)
HP-10wk PF-10wk
Mean SEM Mean SEM
Final body weight 364 9 426* 11
Epididymal fat pads weight
g 9·14 0·41 17·03* 1·05
g/100g of Body weight 2·49 0·10 4·05* 0·15
Perirenal fat pads weight
g 9·44 0·68 19·57* 1·43
g/100g of Body weight 2·58 0·17 4·65* 0·23
Food intake (g/d) 15·68 0·26 22·26* 0·34
Energy intake (kJ/d) 221·4 3·84 335·5* 5·1
HP-10wk, HP diet administered for 10 weeks; PF-10wk, PF diet administered for
10 weeks.
* Significant differences at P< 0·001 (Student’s t test).
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in body weight, PF-W rats showed no changes in fat deposit
weight (Table 4). As seen in the 10-week treatment, PF-16-wk
rats were hyperphagic, and 6 weeks of whey administration
reduced food and energy intake by 16% (Table 4). This
reduction was noticeable around day 10 of diet exposure, and






















































Fig. 1. Energy intake of rats fed high-phyto-oestrogen (HP-10wk, ) or phyto-oestrogen-free (PF-10wk, ) diets for 10 weeks. Data shown are presented as
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Fig. 2. Hypothalamic expression of (a) cocaine-amphetamine-related transcript, (b) pro-opiomelanocortin, (c) agouti-related protein and (d) neuropeptide Y in rats fed
high-phyto-oestrogen (HP-10wk) or phyto-oestrogen-free (PF-10wk) diets for 10 weeks. Relative RNA expression was measured by quantitative real-time RT-PCR
and is expressed as fold change from HP 10-wk values. Expression was normalised to that of ribosomal protein L19. Data shown are presented as means (n 6), with
their standard errors. * Significant differences at P< 0·05 (Student’s t test).
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The reduction in energy intake was associated with changes
in the hypothalamic expression of neuropeptides. In line
with the results observed in animals that were treated for
10 weeks, PF-16-wk rats showed an orexigenic response with
reduced POMC and increased AgRP expression v. the HP-16-wk
group (P< 0·001) (Fig. 4). Nevertheless, NPY and CART mRNA
levels were unchanged. The reduced energy intake observed in
PF-W rats with respect to PF-16-wk rats was linked to an
increase in POMC mRNA levels (P< 0·001), although AgRP
expression remained similar to that in PF-16-wk animals
(P< 0·001) (Fig. 2).
Whey administration did not prevent hormonal changes
induced by phyto-oestrogen deprivation. The blood hormone
profile of the animals is shown in Table 5; 16 weeks of phyto-
oestrogen deprivation increased the levels of total T4 and reduced
levels of E2 compared with the HP-16-wk group. Whey adminis-
tration did not prevent these changes. Thyroid-stimulating hor-
mone and testosterone levels were not affected by the treatment.
Whey administration did not improve glucose metabolism
impaired by 16 weeks of phyto-oestrogen deprivation. In
this study, 16 weeks of phyto-oestrogen deprivation increased
fasting blood glucose and insulin levels, leading to a higher
HOMA index (Table 6), indicating insulin resistance. PF-W
rats showed similar fasting glucose and reduced insulin
concentrations (v. PF-16-wk rats), although this reduction was
not sufficient to affect the HOMA index (v. PF-16-wk rats).
Discussion
This study demonstrates for the first time that obese
phyto-oestrogen-deprived male rats fed whey display a food
intake reduction and an alteration in the gene expressions of
food intake-regulating hypothalamic neuropeptides. However,
the dietary treatment with whey for 6 weeks was unable to
prevent obesity induced by phyto-oestrogen deprivation in the
adult stage of life. We consider that this rat model is suitable for
the study of human obesity, because it evaluates the effects of
whey in obese individuals, when energy intake is increased and
hypothalamic neuropeptides are already altered, reflecting an
actual background of chronic obesity.
We have recently reported that if male rats consume phyto-
oestrogens until they reach adult life, and if the feed is replaced
by a PF diet, rats develop an obese phenotype with diabetes
and alterations in energy intake mediated by a hypothalamic
orexigenic neuropeptide response. These results were achieved
with a 15-week dietary treatment(3). We now showed that
10 weeks of phyto-oestrogen deprivation is enough to cause
obesity with increased adiposity and body weight, but not to
induce diabetes. Replacing the HP diet by a PF diet resulted in
obesity due to an anabolic process, with changes in food intake
mediating the weight gain at least in part. However, we cannot
rule out that alteration in other mechanisms such as energy
expenditure may also be involved. As previously seen(3),
hypothalamic neuropeptide signals mediate this process; phyto-
oestrogen deprivation for 10 weeks significantly decreased
POMC and increased AgRP mRNA, implying that energy intake
is increased at least partially through these systems. Regarding
the paradoxical increase in NPY gene expression, it has been
reported that the Agrp/Npy neurons primarily sense energy
deficits, whereas the Pomc/Cart neurons primarily sense energy
excess, as reported by Barsh & Schwartz(27). These authors also
indicated that Npy mRNA levels are up-regulated by starvation
but are not always affected by energy excess.
The current results on the effects of 10 or 16 weeks of phyto-
oestrogen deprivation in adult male rats were obtained by
feeding animals a semi-synthetic AIN-based diet. The formula-
tion of this diet made possible to manipulate the macronutrient
composition, allowing the replacement of casein (the source of
Table 3. Glucose metabolism parameters in animals-fed high-
phyto-oestrogen (HP) or phyto-oestrogen-free (PF) diet for 10 weeks
(Mean values with their standard errors, n 6)
HP-10wk PF-10wk
Mean SEM Mean SEM
Insulin (mU/l) 31·12 3·05 35·50 4·72
Fasting glucose (mM) 5·86 0·29 6·10 0·35
HOMA 8·16 0·93 9·52 1·13
HP-10wk, HP diet administered for 10 weeks; PF-10wk, PF diet administered for
10 weeks; HOMA, homoeostasis model assessment.
Table 4. Final body and adipose tissue weights and food and energy intake in animals-fed high-phyto-oestrogen (HP) diet, phyto-oestrogen-free (PF) diet or
PF diet supplemented with whey (PF-W)
(Mean values with their standard errors, n 6)
HP-16wk PF-16wk PF-W
Mean SEM Mean SEM Mean SEM
Final body weight 459a 6 484b 5 469a,b 6
Epididymal fat pads weight
g 14·22a 0·66 21·66b 0·44 20·05b 0·93
g/100 g of Body weight 2·86a 0·15 4·52b 0·09 4·40b 0·12
Perirenal fat pads weight
g 14·66a 1·07 26·66b 0·48 24·21b 1·18
g/100 g of Body weight 3·86a 0·18 5·46b 0·07 5·28b 0·16
Food intake (g/d) 15·11a 0·13 22·17b 0·31 18·48c 0·25
Energy intake (kJ/d) 215a 2 334b 5 279c 4
HP-16wk, HP diet administered for 16 weeks; PF-16wk, PF diet administered for 16 weeks.
a,b,c Mean values within a row with unlike superscript letters were significantly different at P<0·05 (Tukey’s test after one-way ANOVA).
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dietary proteins recommended by the American Institute of
Nutrition for rodent diets(21)) by whey protein concentrates to
assess their potential beneficial effects. The amount of phyto-
oestrogens added to obtain the HP diet was similar to that
present in regular laboratory chow, in which soya is used as the
main source of protein(28).
Feeding the PF diet for 16 weeks exacerbated the accretion of
fat tissue and the body weight gain observed in animals treated
for 10 weeks. Hyperphagia and excessive energy intake also
persisted, but with the same magnitude as that observed in
PF-10-wk v. HP-10-wk rats. However, orexigenic hypothalamic
signalling was more prominent: AgRP mRNA expression was
1·55-fold higher in PF-10-wk rats than in HP-10-wk rats and 2·1-
fold higher in PF-16-wk rats than in HP-16-wk rats. These results
show that as the dietary treatment progresses, AgRP expression
increases to maintain the hyperphagic behaviour.
The switch to PF diet in adulthood generates obesity and
glucose homoeostasis impairment. In this study, we aimed to
investigate whether these effects could be attenuated using
whey as a source of dietary protein, as it has numerous well-
known health benefits. We observed that whey administration
for 6 weeks was not enough to affect body weight or epididy-
mal or perirenal fat pad weight. Zhou et al.(12) reported that
whey administration reduced body fat and body weight gain in
Sprague–Dawley rats, but the dietary treatment was longer
(10 weeks) and whey was provided in the context of a high-
protein diet, which is known to promote weight loss(29).
Pezeshki et al.(14) showed that whey significantly reduced fat
mass in obese rats, but the animals were obesity-prone rats
previously fed a high-fat diet. These authors also reported that
whey reduced energy expenditure in these animals, indicating
that this mechanism plays a role in the anti-obesity effect of
whey proteins. Therefore, the strain of the animals, their
preceding obese or lean status, the amount of dietary proteins
and the duration of the experimental protocol may affect the
ability of whey to alter body weight and adiposity. Besides, the
number of animals in each group in our study could have been






























a a a a a a a
a a

































b b b b
b



















Fig. 3. Energy intake of rats fed high-phyto-oestrogen (HP-16wk, ),
phyto-oestrogen-free (PF-16wk, ) or phyto-oestrogen-free+whey
(PF-W, ) diets. Data shown are presented as means (n 6), with their
standard errors. a,b,c Unlike letters indicate significant differences (P<0·05 by
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Fig. 4. Hypothalamic expression of (A) cocaine-amphetamine-related transcript, (B) pro-opiomelanocortin, (C) agouti-related protein and (D) neuropeptide Y in rats
fed high-phyto-oestrogen (HP-16wk), phyto-oestrogen-free (PF-16wk) or phyto-oestrogen-free +whey (PF-W) diets. Relative RNA expression was measured by
quantitative real-time RT-PCR and is expressed as fold change from HP-16wk values. Expression was normalised to that of ribosomal protein L19. Data shown are
presented as means (n 6), with their standard errors. a,b Mean values with unlike letters were significantly different at P< 0·05 (Tukey’s test after one-way ANOVA).
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Our results show that whey administration significantly
reduced food and energy intake. This was associated with an
increase in the anorexigenic signal of POMC, although AgRP
expression remained unchanged compared with PF-16-wk ani-
mals. It was also noticeable that energy intake in PF-W remained
higher than in HP animals. This could suggest involvement of
other neuropeptides such as orexins or changes in hedonic
mechanisms of food intake control. The greater satiating effect
of whey protein is in agreement with results by other
authors(10,11,30); however, the mechanisms involved in food
intake are still unknown. Pezeshki et al.(14) showed that the
satiating effect was related to a reduction in taste preference.
Hall et al.(30), reported an increased satiety response to whey
with respect to casein in human subjects and stated that this
response was mediated by plasma amino acids and gastro-
intestinal hormones. The influx of amino acids following inges-
tion of whey proteins is also an important factor in the effect of
whey on food intake. It is widely known that different amino
acids and proteins affect peripheral and central mechanisms
involved in food intake control(31). Whey proteins contain a high
concentration of branched-chain amino acids(32), with L-leucine
representing about 10% of the total amino acids of whey(7). The
importance of leucine in the hypothalamic food intake reg-
ulatory system has been reported, as its intracerebroventricular
injection has been shown to suppress food intake. This effect
has been related to increased mammalian target of rapamycin
(mTOR) activity in the hypothalamus, which leads to the sti-
mulation of POMC expression(33), in agreement with our results.
It has been previously reported that phyto-oestrogen
deprivation modifies endocrine homoeostasis(3,34,35).
Phyto-oestrogen-deprived rats showed higher circulating total
T4 and slightly (but not significant) decreased thyroid-
stimulating hormone, probably as a consequence of negative
feedback from T4. Other authors have reported that
phyto-oestrogens, particularly genistein, reduce circulating
thyroid hormone levels, as they affect their synthesis, metabo-
lism and thyroid hormone transport proteins(36). In our study,
the presence of whey in the diet was unable to prevent these
alterations. The potential effects of whey on the thyroid system
remain unknown. It has been recently reported that 36 weeks of
treatment with whey did not interfere with thyroid status in
overweight human subjects(37), in agreement with our results.
A plausible mechanism by which phyto-oestrogen depriva-
tion may exert several effects could be through a reduction in
circulating E2 levels
(3). Our present results also showed
decreased serum E2 concentrations in phyto-oestrogen-
deprived rats, which could not be prevented by dietary
supplementation with whey.
One of the most remarkable alterations induced by phyto-
oestrogen deprivation is the impairment of glucose
homoeostasis – a hallmark of insulin resistance and
diabetes(3,35,38). In the present study, the exacerbation of
adiposity observed in PF-16-wk rats was concomitant with the
appearance of diabetes and insulin resistance. This was reflec-
ted by high levels of fasting glucose combined with increased
levels of circulating insulin and the consequent high HOMA
index, in agreement with previous results(3). The marked fat
accretion observed in the last 6 weeks of treatment appeared to
be essential in the onset of diabetes in phyto-oestrogen-
deprived male rats, and whey administration did not prevent
the increase in fat depots or the high levels of fasting glucose.
Whey proteins have been reported to improve glucose
Table 5. Blood hormones in animals fed high-phyto-oestrogen (HP) diet, phyto-oestrogen-free (HP) diet or PF diet supplemented with
whey (PF-W)
(Mean values with their standard errors, n 6)
HP-16wk PF-16wk PF-W
Mean SEM Mean SEM Mean SEM
Thyroid system hormones
Total thyroxine (nmol/l) 21·16a 1·43 41·22b 1·29 44·98b 2·44
Thyroid-stimulating hormone (ng/ml) 3·67 0·45 2·78 0·35 2·51 0·40
Sex hormones
Testosterone (ng/ml) 1·08 0·22 0·48 0·08 1·09 0·27
Oestradiol (pg/ml) 5·44a 0·41 2·15b 0·53 1·12 0·36
HP-16wk, HP diet administered for 16 weeks; PF-16wk, PF diet administered for 16 weeks.
a,b Mean values within a row with unlike superscript letters were significantly different at P<0·05 (Tukey’s test after one-way ANOVA).
Table 6. Glucose metabolism parameters in animals in animals fed high-phyto-oestrogen (HP) diet, phyto-oestrogen-free (PF) diet or
PF diet supplemented with whey (PF-W)
(Mean values with their standard errors, n 6)
HP-16wk PF-16wk PF-W
Mean SEM Mean SEM Mean SEM
Insulin (mU/l) 29·88a 0·86 43·67b 0·99 35·81c 2·51
Fasting glucose (mM) 5·21a 0·24 7·76b 0·13 8·58b 0·23
HOMA 6·49a 0·36 14·78b 0·49 13·55b 0·75b
HP-16wk, HP diet administered for 16 weeks; PF-16wk, PF diet administered for 16 weeks; HOMA, homoeostasis model assessment.
a,b,c Mean values within a row with unlike superscript letters were significantly different at P<0·05 (Tukey’s test after one-way ANOVA).
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homoeostasis(15–17). Our results showed that, although whey
administration did not reduce circulating glucose, circulating insulin
levels were reduced when compared with PF-16-wk rats, which
could be considered an improvement in insulin resistance. This
result is in agreement with that found by Tong et al.(39), who
showed that administration of whey proteins for 8 weeks
decreased circulating insulin in rats previously fed a high-fat diet,
and attributed this effect to the high concentration of leucine in
whey proteins. Moreover, Belobrajdic et al.(40) reported that dietary
whey reduces plasma insulin concentration compared with red
meat, but only when provided along with a high-protein diet.
The present study demonstrated that whey administration
reduces food intake and affects hypothalamic gene expression in
obese phyto-oestrogen-deprived male rats. An increase in POMC
expression was the main anorexigenic hypothalamic signal
affected by dietary whey. On the other hand, 6 weeks of treat-
ment was not enough to affect body weight or fat pad weights.
Phyto-oestrogen deprivation modified endocrine homoeostasis,
affecting total T4 and E2, and whey administration could not
prevent these changes. High levels of circulating glucose were
not prevented by whey administration; however, the reduction in
fasting insulin is a promising result for a possible beneficial effect
of whey with a longer treatment. Our results should encourage
further studies considering the potential of whey proteins to
reduce food intake and circulating insulin.
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